Medical/Pharmaceuticals
BioVaxys And Bioproduction Partner Bio Elpida Begin Construction Of GMP Facility To Produce Clinical Supply For Planned Ovarian Cancer Vaccine Study
VANCOUVER, BC and LYON, France, June 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (US OTCQB: BVAXF)("BioVaxys" or "the Company") is pleased to announce that its bioproduction partner Bio Elpida of Lyon, France, has initiated construction of a new Good Manufacturing Prac...
2021-06-01 20:00
4948
Occlutech takes important step towards approval in China
SCHAFFHAUSEN, Switzerland, June 1, 2021 /PRNewswire/ -- Occlutech AG ("Occlutech" or the "Company") today announces that the planned recruitment of 180 patients has been reached in the Company's trial inChina for its ASD Occluder. The Occlutech ASD Occluder is used in the treatment of Atrial Sept...
2021-06-01 19:02
2644
Scripps Research Institute testing shows Viraleze highly active against UK COVID strain
MELBOURNE, Australia, June 1, 2021 /PRNewswire/ -- Australia's Viraleze anti-COVID nasal spray is active against the highly infectious UK variant of SARS-CoV-2, the virus that causes COVID-19, reducing infectivity of the virus by >98%, it was announced today in a major development for the product...
2021-06-01 17:30
2144
Australia's original prolonged-release melatonin now available over the counter at pharmacies
MAIN POINTS * Circadin® prolonged-release melatonin is now available without prescription1 * Circadin® is clinically proven in people aged 55 and over2 to help them fall asleep quicker, sleep better, wake refreshed, and in turn improve quality of life3 * Circadin® mimics the effect of the b...
2021-06-01 17:05
2340
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis
Agreement Renews Successful Global Collaboration That led to Several Groundbreaking Therapies in Multiple Disease Areas KHK4083 Depletes OX40-Expressing T cells Associated with Atopic Dermatitis and Several Other Inflammatory Diseases Moderate-to-Severe Atopic Dermatitis Affects Nearly 30 Mill...
2021-06-01 16:00
5578
100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand
CHRISTCHURCH, New Zealand, June 1, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that St George's Hospital inChristchurch, New Zealand, has ordered an Elekta Unity MR-Linac, making it the 100th device sold since introduction. Today, the innovative radiation therapy device is found in 14 count...
2021-06-01 15:07
5264
AVATAMED sets up Joint Service Lab with A*STAR's Institute of Molecular and Cell Biology to offer Precision Oncology Services
SINGAPORE, June 1, 2021 /PRNewswire/ -- AVATAMED (www.avatamed.com
2021-06-01 09:00
2803
Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China
SAN FRANCISCO and SUZHOU, China, June 1, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...
2021-06-01 08:00
5301
PENTAX Medical and Vedkang Establish Endoscopic Therapeutics Joint Venture
TOKYO, May 31, 2021 /PRNewswire/ -- PENTAX Medical (a division of HOYA Group) and Jiangsu Vedkang Medical Science and Technology Co., Ltd (Vedkang) today announced the establishment of a joint venture- PENTAX Medical Therapeutics ( Jiangsu) Co., Ltd.(*) to develop single-use therapeutics products ...
2021-05-31 21:00
3021
PolyU develops biomimetic nanosheet for cancer therapy and imaging
HONG KONG, May 31, 2021 /PRNewswire/ -- A research team from the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) has developed a novel type of biomimetic nanosheet with a multi-modal imaging function, which can track tumour development ...
2021-05-31 19:42
3129
RhoVac Confirms Forecast - BRaVac Phase IIb study recruitment to close in Quarter 3 2021
STOCKHOLM, May 31, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today,May 31, 2021, that it confirms its previous forecast to be able to conclude recruitment for its multi-centre BRaVac Phase IIb study in Quarter 3 2021. Also, all new US clinics hav...
2021-05-31 19:33
2197
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery
SINGAPORE, May 31, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, announced the approval by the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic brain injury (TBI). Moleac is dedicated in finding, devel...
2021-05-31 18:33
3020
Mindray Defines Future of Imaging Technologies with New General Imaging, Women's Healthcare and Cardiology Ultrasound Solutions
SHENZHEN, China, May 31, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the launch of its new General Imaging, Women's Healthcare, and Cardiology ultrasound solutions onMay 28, 2021. Underpinned by the theme "In...
2021-05-31 10:15
8806
Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
* HMBD-002 is the only IgG4 isotype anti-VISTA antibody currently in development * HMBD-002 is anticipated to enter a Phase 1 clinical trial in 2021 HOUSTON andSINGAPORE, May 31, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing pr...
2021-05-31 10:00
2336
An Taiwanese Hearing-impaired Actor, Easton Dong Calls Out the "Listen Love" Project, to Raise Concerns for Hearing-impaired Students during the Covid-19 Pandemic.
TAIPEI, May 31, 2021 /PRNewswire/ -- The "Listen Love" donation project, led by Easton Dong, a hearing-impaired actor inTaiwan, and co-sponsored by TaerInno, aims to bring transparent masks to hearing-impaired students. Mr. Dong advocates this campaign to bring people awareness of difficulties en...
2021-05-31 08:00
2682
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.
SEOUL, South Korea, May 30, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced onMay 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American new drug developer, for about5.5 million U.S. dollars. As a result, Nexturn...
2021-05-30 22:00
5288
Year-end report, May-April 2020/21
Accelerated order growth STOCKHOLM, May 28, 2021 /PRNewswire/ -- During Elekta's fourth quarter, we drove strong order growth in all regions – both from market growth and market share gain – and we received our 100th Unity order. Installation volumes were similar to levels in the fourth quarter ...
2021-05-28 14:24
13653
CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application
* Sugemalimab becomes the world's first anti-PD-1/PD-L1 monoclonal antibody to successfully improve progression-free survival (PFS) in patients with stage III non-small-cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy * Sugemalimab is also t...
2021-05-28 08:10
9094
Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of Myelodysplastic Syndrome
SHANGHAI and HONG KONG, May 28, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-05-28 08:00
3958
Essence SmartCare Launches VitalOn Remote Patient Monitoring Solution
Leading Connected Homecare Solutions Provider Adds Advanced Health Monitoring
Platform to Existing Senior Care Offering
HERZLIYA, Israel, May 28, 2021 /PRNewswire/ -- Essence SmartCare
2021-05-28 07:00
2675
Week's Top Stories
Most Reposted
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
[Picked up by 331 media titles]
2026-05-05 10:01Agoda Makes it Easier for Travelers to See Relevant Photos in Reviews
[Picked up by 313 media titles]
2026-05-06 12:00
AVPN AI Opportunity Fund Expands to Build AI-Ready Generations Across Asia by Empowering Educators and Youth Across Asia-Pacific
[Picked up by 298 media titles]
2026-05-05 09:00Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 293 media titles]
2026-05-11 16:20
Colebrook Bosson Saunders Expands Flo X Multi Compatibility for Curved Ultrawide Monitors
[Picked up by 290 media titles]
2026-05-05 11:00
Most Read
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
2026-05-05 10:01
8179
Amadeus delivers solid Q1 2026 growth, and maintains commercial momentum
2026-05-08 18:30
7503
Massimo Group Launches Sentinel 770 HVAC as Part of Sentinel Product Line Targeting Approximately US$10 Million in 2026 Revenue
2026-05-06 21:20
7035
LightInTheBox to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
2026-05-06 20:00
6995
